Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20040211429 A1
Publication typeApplication
Application numberUS 10/846,047
Publication date28 Oct 2004
Filing date14 May 2004
Priority date7 Jun 1995
Also published asCA2221332A1, CA2221332C, DE69631069D1, DE69631069T2, EP0957844A1, EP0957844A4, EP0957844B1, US6145505, US6176240, US6679266, US6871650, US7428904, US8066007, US20020100480, US20040159324, US20040163651, US20040206358, US20070044808, US20070144528, WO1996040023A1
Publication number10846047, 846047, US 2004/0211429 A1, US 2004/211429 A1, US 20040211429 A1, US 20040211429A1, US 2004211429 A1, US 2004211429A1, US-A1-20040211429, US-A1-2004211429, US2004/0211429A1, US2004/211429A1, US20040211429 A1, US20040211429A1, US2004211429 A1, US2004211429A1
InventorsJulian Nikolchev, Dai Ton, Amy Thurmond
Original AssigneeConceptus, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Contraceptive transcervical fallopian tube occlusion devices and their delivery
US 20040211429 A1
Abstract
The invention provides intrafallopian devices and non-surgical methods for their placement to prevent conception. The efficacy of the device is enhanced by forming the structure at least in part from copper or a copper alloy. The device is anchored within the fallopian tube by imposing a secondary shape on a resilient structure, the secondary shape having a larger cross-section than the fallopian tube. The resilient structure is restrained in a straight configuration and transcervically inserted within the fallopian tube, where it is released. The resilient structure is then restrained by the walls of the fallopian tube, imposing anchoring forces as it tries to resume the secondary shape.
Images(5)
Previous page
Next page
Claims(72)
1-31. (canceled)
32. A method for sterilizing a female patient using an elongated instrument assembly having a distal end, said method comprising:
inserting the distal end of the elongated instrument assembly transcervically into the female patient, the distal end of the elongated instrument having a detachable body which includes a non-biodegradable material;
applying energy from the elongated instrument to a surrounding tissue of a fallopian tube of said female patient;
detaching the detachable body from the distal end of the elongated instrument assembly; and
removing a remaining portion of the elongated instrument assembly from the female patient, wherein a scar formation in a region of the surrounding tissue permanently attaches to the detachable body.
33. The method of claim 32 wherein the energy comprises electrical energy and wherein the scar formation encapsulates the detachable body.
34. A method as in claim 32 wherein said detachable body is resilient and imposes an anchoring force against said surrounding tissue.
35. A method as in claim 32 wherein said elongated instrument assembly comprises a conductive interface which is coupled to a surface assembly which is coupled to said elongated instrument assembly.
36. A method as in claim 32 wherein said elongated instrument assembly comprises an elongate body and a shaft which is disposed within said elongate body.
37. A method as in claim 32 wherein said applying precedes said detaching of said detachable body.
38. A method as in claim 32 wherein said detachable body has a first configuration prior to said detaching and a second configuration after said detaching.
39. A method as in claim 38 wherein said first configuration has an outer diameter which is less than an inner diameter of said fallopian tube.
40. A method as in claim 32 wherein said detachable body comprises a polymer material.
41. A method comprising:
inserting a catheter having an electrically conductive surface assembly mounted on a distal end of the catheter through the vagina and the cervical canal of a patient and into the uterus of the patient;
advancing a detachable assembly, which is coupled to the catheter, into a fallopian tube of the patient, said detachable assembly including a non-biodegradable material;
applying electrical energy to the electrically conductive surface assembly;
detaching the catheter from the detachable assembly, wherein a permanent scar formation in the fallopian tube encapsulates the detachable assembly.
42. A method as in claim 41 wherein said detachable assembly is resilient and imposes an anchoring force against the fallopian tube.
43. A method as in claim 41 wherein said catheter comprises a conductive interface which is coupled to said electrically conductive surface assembly.
44. A method as in claim 41 wherein said catheter comprises an elongate body and a shaft which is disposed within said elongate body.
45. A method as in claim 41 wherein said applying precedes said detaching of said detachable assembly.
46. A method as in claim 41 wherein said detachable assembly has a first configuration prior to said detaching and a second configuration after said detaching.
47. A method as in claim 46 wherein said first configuration has an outer diameter which is less than an inner diameter of said fallopian tube.
48. A method as in claim 41 wherein said detachable assembly comprises a polymer material.
49. A method as in claim 44 wherein said catheter further comprises a lumen through which said shaft is slidable.
50. A method as in claim 41 wherein said applying said electrical energy is through a shaft within a lumen of said catheter.
51. An intrafallopian delivery system for transcervical introduction of a device, the delivery system comprising:
a first portion having an elongate body and a shaft for delivering energy;
a second portion detachably coupled to said elongate body, said second portion including a non-biodegradable material and being sized to fit within a fallopian tube and being detachable from said elongate body to remain permanently within said fallopian tube and wherein said energy causes a scar formation, in said fallopian tube, which attaches to said second portion.
52. A delivery system as in claim 51 wherein said energy comprises electrical energy and wherein said shaft delivers electrical current.
53. A delivery system as in claim 51 wherein said second portion is resilient and imposes an anchoring force against said fallopian tube.
54. A delivery system as in claim 51 wherein said shaft is disposed within a lumen of said elongate body.
55. A delivery system as in claim 51 wherein said energy is delivered before said second portion is detached from said elongate body.
56. A delivery system as in claim 51 wherein said second portion has a first configuration prior to being detached and a second configuration after being detached.
57. A delivery system as in claim 56 wherein said first configuration has an outer diameter which is less than an inner diameter of said fallopian tube.
58. A delivery system as in claim 51 wherein said second portion comprises a polymer material.
59. A delivery system as in claim 51 further comprising an introducer through which said elongate body is inserted.
60. A delivery system as in claim 51 wherein said second portion has a surface which attaches to said scar formation.
61. An intrafallopian catheter system for transcervical introduction of an intrafallopian device, said catheter system comprising:
an elongate body having a shaft for delivering electrical energy;
a detachable body which is detachably coupled to said elongate body, said detachable body including a non-biodegradable material and being sized to fit within a fallopian tube and being detachable from said elongate body to remain permanently within said fallopian tube and wherein said electrical energy causes a scar formation, in said fallopian tube, which encapsulates said detachable body.
62. A catheter system as in claim 61 wherein said detachable body is resilient and imposes an anchoring force against said fallopian tube.
63. A catheter system as in claim 61 wherein said shaft is disposed within a lumen of said elongate body.
64. A catheter system as in claim 61 wherein said electrical energy is delivered before said detachable body is detached from said elongate body.
65. A catheter system as in claim 61 wherein said detachable body has a first configuration prior to being detached and a second configuration after being detached.
66. A catheter system as in claim 65 wherein said first configuration has an outer diameter which is less than an inner diameter of said fallopian tube.
67. A catheter system as in claim 61 wherein said detachable body comprises a polymer material.
68. A catheter system as in claim 61 further comprising an introducer through which said elongate body is inserted.
69. A catheter system as in claim 61 wherein said detachable body has a surface which attaches to said scar formation.
70. A method for sterilizing a female patient, said method comprising:
delivering a body transcervically into the female patient, said body including a non-biodegradable material;
delivering energy to a surrounding tissue of a fallopian tube of said female patient;
wherein a scar formation in a region of the surrounding tissue permanently attaches to the body.
71. The method of claim 70 wherein the energy comprises electrical energy and wherein the scar formation encapsulates said body.
72. A method as in claim 70 wherein said body is resilient and imposes an anchoring force against said surrounding tissue.
73. A method as in claim 70 wherein an elongated instrument assembly delivers said body and is detachably coupled to said body.
74. A method as in claim 70 wherein said body is not expelled from said fallopian tube.
75. A method as in claim 70 wherein said body comprises a polymer material.
76. A method as in claim 70 wherein said body has a first configuration prior to said delivering and a second configuration after said delivering.
77. A method as in claim 76 wherein said first configuration has an outer diameter which is less than an inner diameter of said fallopian tube.
78. A method as in claim 70 wherein said body comprises an open outer wall which allows tissue ingrowth into said body.
79. An intrafallopian delivery system for transcervical introduction of a device, the delivery system comprising:
a first portion having an elongate body;
a second portion detachably coupled to said elongate body, said second portion including a non-biodegradable material and being sized to fit within a fallopian tube in an area exposed to energy to damage tissue in said fallopian tube and being detachable from said elongate body to remain permanently within said fallopian tube and wherein said energy causes a scar formation, in said fallopian tube, which attaches to said second portion.
80. A delivery system as in claim 79 wherein said energy comprises electrical energy.
81. A delivery system as in claim 79 wherein said second portion is resilient and imposes an anchoring force against said fallopian tube.
82. A delivery system as in claim 79 wherein said energy is delivered before said second portion is detached from said elongate body.
83. A delivery system as in claim 79 wherein said second portion has a first configuration prior to being detached and a second configuration after being detached.
84. A delivery system as in claim 83 wherein said first configuration has an outer diameter which is less than an inner diameter of said fallopian tube.
85. A delivery system as in claim 79 wherein said second portion comprises a polymer material.
86. A method for sterilizing a female patient, said method comprising:
delivering a body transcervically into the female patient, said body having an open outer wall which allows tissue ingrowth into said body;
delivering energy to a surrounding tissue of a fallopian tube of said female patient;
wherein a scar formation in a region of the surrounding tissue permanently attaches to said body.
87. The method of claim 86 wherein the energy comprises electrical energy and wherein the scar formation encapsulates said body.
88. A method as in claim 86 wherein said body is resilient and imposes an anchoring force against said surrounding tissue.
89. A method as in claim 86 wherein an elongated instrument assembly delivers said body and is detachably coupled to said body.
90. A method as in claim 86 wherein said body is not expelled from said fallopian tube.
91. A method as in claim 86 wherein said body comprises a polymer material.
92. A method as in claim 86 wherein said body has a first configuration prior to said delivering and a second configuration after said delivering.
93. A method as in claim 92 wherein said first configuration has an outer diameter which is less than an inner diameter of said fallopian tube.
94. An intrafallopian delivery system for transcervical introduction of a device, the delivery system comprising:
a first portion having an elongate body;
a second portion detachably coupled to said elongate body, said second portion having an open outer wall which allows tissue ingrowth into said second portion and being sized to fit within a fallopian tube in an area exposed to energy to damage tissue in said fallopian tube and being detachable from said elongate body to remain permanently within said fallopian tube and wherein said energy causes a scar formation, in said fallopian tube, which attaches to said second portion.
95. A delivery system as in claim 94 wherein said energy comprises electrical energy.
96. A delivery system as in claim 94 wherein said second portion is resilient and imposes an anchoring force against said fallopian tube.
97. A delivery system as in claim 94 wherein said energy is delivered before said second portion is detached from said elongate body.
98. A delivery system as in claim 94 wherein said second portion has a first configuration prior to being detached and a second configuration after being detached.
99. A delivery system as in claim 98 wherein said first configuration has an outer diameter which is less than an inner diameter of said fallopian tube.
100. A delivery system as in claim 94 wherein said second portion comprises a polymer material.
101. A delivery system as in claim 94 further comprising an introducer through which said elongate body is inserted.
102. A delivery system as in claim 94 wherein said second portion has a surface which attaches to said scar formation.
Description
    BACKGROUND OF THE INVENTION
  • [0001]
    1. Field of the Invention
  • [0002]
    The present invention relates generally to contraception, and more particularly to intrafallopian contraceptive devices and nonsurgical methods for their delivery.
  • [0003]
    Worldwide demand exists for safe, effective methods of both contraception and permanent sterilization. Although a variety of contraception and sterilization methods are available, all of the existing methods have limitations and disadvantages. Thus, the need for additional safe, low cost, reliable methods of contraception and permanent sterilization, both in developed and less developed countries, is widely recognized.
  • [0004]
    Many presently available contraception methods require significant user involvement, and user non-compliance results in quite high rates of failure. While the theoretical effectiveness of existing contraceptives, including barrier methods and hormonal therapies, is well established, overcoming user noncompliance to improve overall efficacy has proven difficult.
  • [0005]
    One form of contraception which is less susceptible to user noncompliance is the intrauterine device (IUD). IUDs have been found to have higher rates of reliability, and are effective for a longer period of time, than most other commercially available contraceptives. Unfortunately, IUDs are also associated with serious infectious complications. For this reason, the use of IUDs within the United States has decreased dramatically. Additionally, IUDs are subject to unplanned expulsion, and must be removed due to excessive pain or bleeding in a percentage of cases, further reducing the acceptance of the IUD as a contraceptive method. Interestingly, the efficacy of copper IUDs appears to be higher than that of non-metallic IUDs. The reason for this has not been fully explained.
  • [0006]
    Commercially available options for permanent sterilization include fallopian tube ligation and vasectomy. These methods are surgical, are difficult to reverse, and are not available to many people in the world. It is common knowledge that fertilization occurs in the fallopian tubes where the sperm and ovum meet. Tubal ligation avoids this by complete occlusion of the fallopian tubes.
  • [0007]
    It has previously been proposed to reversibly occlude the fallopian tubes, for example, by in vitro formation of an elastomeric plug, or otherwise anchoring a device on either side of the narrowest region of fallopian tube, called the “isthmus.” Such fallopian tube occlusion methods appear promising; however, an unacceptably high percentage of the non-surgical devices proposed to date have become dislodged during previous studies. Even where non-surgical intrafallopian devices have remained in place, they have been found to be only moderately effective at preventing conception.
  • [0008]
    For these reasons, it would be desirable to provide effective, reliable intrafallopian devices for contraception and sterilization. It would be particularly desirable to provide highly effective intrafallopian devices which did not require surgery for placement. It would be especially desirable if such devices and methods allowed easy placement of the device, but were less susceptible to being dislodged than previously proposed non-surgical intrafallopian devices.
  • [0009]
    2. Description of the Related Art
  • [0010]
    The experimental use of a stainless steel intrafallopian device is described in Transcatheter Tubal Sterilization in Rabbits, Penny L. Ross, RT 29 “Investigative Radiology”, pp. 570-573 (1994). The experimental use of an electrolytically pure copper wire as a surgical contraceptive intrafallopian device in rats was described in “Antifertility Effect of an Intrafallopian Tubal Copper Device”, D. N. Gupta, 14 Indian Journal of Experimental Biology, pp. 316-319 (May 1976).
  • [0011]
    U.K. Patent Application Pub. No. 2,211,095 describes a uterine screw plug for blocking the fallopian tube. European Patent Application Pub. No. 0,010,812 describes a device for placement in the oviducts having enlargements at either end for anchoring the device. The same device appears to be described in Netherlands Patent No. 7,810,696.
  • [0012]
    The use of tubal occlusion devices is described in “Hysteroscopic Oviduct Blocking With Formed-in-Place Silicone Rubber Plugs”, Robert A. Erb, Ph.D., et al., The Journal of Reproductive Medicine, pp. 65-68 (August 1979). A formed-in-place elastomeric tubal occlusion device is described in U.S. Pat. No. 3,805,767, issued to Erb. U.S. Pat. No. 5,065,751, issued to Wolf, describes a method and apparatus for reversibly occluding a biological tube. U.S. Pat. No. 4,612,924, issued to Cimber, describes an intrauterine contraceptive device which seals the mouths of the fallopian tubes.
  • [0013]
    German Patent No. 28 03 685, issued to Brundin, describes a device for plugging a body duct with a device which swells when in contact with a body fluid.
  • [0014]
    Alternative contraceptive devices are disclosed in copending U.S. patent application Ser. No.______ (attorney docket no. 16355-25), the full disclosure of which is herein incorporated by reference.
  • SUMMARY OF THE INVENTION
  • [0015]
    The present invention provides intrafallopian devices and methods for their placement to prevent conception. The intrafallopian devices of the present invention are transcervically delivered, resiliently anchored structures which are formed at least in part from copper to provide long term contraception, or alternatively permanent sterilization, without the need for surgical procedures or the increased bleeding, pain, and risks of infection associated with intrauterine devices (IUDs).
  • [0016]
    The use of copper in the intrafallopian device of the present invention improves its efficacy as a contraceptive method. Devices formed from plastically deformable materials, however, are less readily restrained in the fallopian tube. Apparently, the large variation in the actual shape and dimensions of fallopian tubes does not provide reliable anchoring for a pre-formed deformable intrafallopian device. The intrafallopian device of the present invention therefore comprises a resilient structure, usually a metallic coil, which includes a copper alloy, a copper plating, or copper fibers, ideally comprising an alloy including at least 75% copper. The coil material typically includes beryllium, zinc, stainless steel, platinum, a shape memory alloy such as Nitinol™, or the like. Preferably, the coil is composed of an alloy of beryllium and copper. Although the present device will generally result in occlusion, it need not completely occlude the fallopian tube to prevent the meeting of the sperm and ovum. Instead, the presence of the copper on the resilient structure is sufficient to provide effective contraception.
  • [0017]
    Conveniently, the present invention further comprises non-surgical placement of such intrafallopian devices by transcervical introduction. The resilient structure is restrainable in a straight configuration, e.g., by inserting the device within a catheter, greatly facilitating and reducing the risks of introduction. Thus, the cost and dangers associated with existing surgical contraceptive and sterilization procedures are avoided.
  • [0018]
    In a first aspect, a contraceptive intrafallopian device according to the present invention comprises a resilient structure having a proximal end and a distal end. The resilient structure comprises copper, and is biased to form at least one bend near the proximal end of the primary coil. Similarly, the resilient structure is also biased to form at least one bend near its distal end. These proximal and distal bends define an isthmus-traversing region therebetween. Preferably, the isthmus-traversing region also includes at least one bend, thereby helping to anchor the coil within the fallopian tube.
  • [0019]
    Generally, the resilient structure of the present intrafallopian device will be formed as a primary coil. To help restrain the coil within the fallopian tube, fibers are attached to some embodiments of the coil, the fibers optionally comprising a polyester material such as Rayons™, Dacron™, or the like. Alternatively, copper fibers may be used to increase the exposed copper surface area, the copper fibers generally having a diameter on the order of 0.001 inches.
  • [0020]
    The bends of the present intrafallopian device are generally formed as a secondary shape imposed on a primary coil. The primary coil is most easily formed as a straight cylindrical coil. The secondary shape will be imposed on the primary coil by bending, optionally heat treating the primary coil while bent. The individual bends may take a wide variety of forms, including sinusoidal curves, the individual loops of a continuous secondary coil, or the like. However, the secondary shape generally defines an overall width which is larger than the fallopian tube, so that the tubal wall restrains the resilient structure when it is released.
  • [0021]
    Preferably, each of the bends of the present intrafallopian device forms a loop in the primary coil when in a relaxed state. Ideally, the loops are separated by straight sections of coil. The alternating of loops with straight sections of coil forms a large diameter “flower coil,” which provides a large relaxed overall width, and also features bends of tight radius, both of which promote retention. Conveniently, the primary coil generally has a diameter less than that of the fallopian tube, and can be restrained in a straight configuration for placement within the fallopian tube, typically by inserting the primary coil within a delivery catheter.
  • [0022]
    In another aspect, a contraceptive intrafallopian device according to the present invention comprises a resilient primary coil having a primary coil diameter. The primary coil comprises copper, and forms a secondary shape when in a relaxed state. The secondary shape defines a plurality of bends and an overall width which is larger than the primary coil diameter. Thus the primary coil can be easily anchored in a fallopian tube which is smaller in diameter than the secondary shape. Preferably, the present device reacts with a force sufficient to prevent axial movement of the device within the fallopian tube when restrained in a lumen having a diameter in the range between 0.5 mm and 3 mm. The actual anchoring force will depend on the shape of the coil and the modulus of elasticity of the material used.
  • [0023]
    In yet another aspect, a intrafallopian contraceptive delivery system according to the present invention comprises an elongate body in which the resilient primary coil described above is slidably disposed. A shaft is also slidably disposed within the elongate body and is located proximally of the primary coil. The distal end of the shaft includes a coil interface surface, while the elongate body restrains the primary coil in a straight configuration.
  • [0024]
    Preferably, a bend in the isthmus-traversing region of the present intrafallopian device, together with the proximal and distal anchor bends, restrains the resilient structure within the isthmus of the fallopian tube. The distal anchor is inserted into the ampulla, distal of the isthmus, while the proximal anchor is located in the ostium, proximal of the isthmus. Unintended movement of the device is further avoided by locating the isthmus-traversing region within the isthmus to resiliently impose anchoring forces against the tubal wall.
  • [0025]
    In a still further aspect, an intrafallopian contraceptive method according to the principles of the present invention comprises restraining a resilient structure in a straight configuration and transcervically inserting the resilient structure into a fallopian tube. The resilient structure is affixed within the isthmus by releasing a bent isthmus-traversing region. The bend of the isthmus-traversing region exerts a force against the wall of the fallopian tube, anchoring the device within the isthmus. Preferably, a distal anchor on the resilient structure is released distally of the isthmus, and a proximal anchor is released proximally of the isthmus, the distal and proximal anchors generally formed from bends in the resilient structure. Optionally, an electric current is applied through the resilient structure to the fallopian tube, thereby effecting permanent sterilization.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0026]
    [0026]FIG. 1 illustrates a first embodiment of a contraceptive intrafallopian device according to the present invention having a single distal anchor loop, a single proximal anchor loop, and an isthmus-traversing region having a single loop for anchoring the device within the fallopian tube.
  • [0027]
    [0027]FIG. 2 illustrates an alternative embodiment of a contraceptive intrafallopian device according to the present invention having a plurality of loops which may act as proximal, distal, or lumen anchors.
  • [0028]
    [0028]FIG. 3 illustrates the distal portion of a delivery catheter for placement of a contraceptive intrafallopian device according to the present invention.
  • [0029]
    [0029]FIG. 4 illustrates the contraceptive intrafallopian device of FIG. 1 partially released from the delivery catheter of FIG. 3.
  • [0030]
    [0030]FIGS. 5 and 6 illustrate a contraceptive method using an intrafallopian device according to the principles of the present invention.
  • DETAILED DESCRIPTION OF THE SPECIFIC EMBODIMENT
  • [0031]
    The present invention encompasses a contraceptive intrafallopian device which can alternatively be used as both a permanent and a reversible means of contraception. The present contraceptive methods and devices minimize the danger of non-use which has limited the efficacy of prior art contraceptive techniques. Moreover, the location of the present devices within the fallopian tubes provides a reduced risk of the infectious complications, increased bleeding, and pelvic pain associated with intrauterine devices (IUDs). Furthermore, the location and the novel shape of the present intrafallopian device provides significant advantages over IUDs, which have been found to be susceptible to unplanned expulsion and removal due to excessive pain and bleeding. The present invention takes advantage of the increase in effectiveness associated with copper IUDs, providing a resilient structure including copper which may be transcervically positioned without the need for surgery.
  • [0032]
    Although the present contraceptive method may be included within a group of contraceptive techniques generally referred to as fallopian tube occlusion methods, the present invention does not necessarily rely solely on blocking the fallopian tube to prevent fertilization. Instead, contraception is apparently provided by disrupting of ovum transport, the process of fertilization, and/or cleavage of the ovum. While the effect that copper has on these processes is not fully understood, it does appear that copper intrafallopian devices offer potentially significant increases in effectiveness over intrafallopian devices formed of other materials. Optionally, the present invention further encompasses devices which promote tissue growth within the tube to induce tubal occlusion, further inhibiting conception.
  • [0033]
    The present invention is anchored within the isthmus of the fallopian tube, overcoming the unintended expulsion of the device and the resulting failure of the contraceptive method. Such intrafallopian device expulsion has been the single greatest factor limiting the efficacy of easily positioned intrafallopian contraceptive techniques.
  • [0034]
    The present intrafallopian devices are generally elongate resilient structures pre-formed into secondary shapes. These secondary shapes will bias the resilient structure so as to provide strong forces against the lumen wall of the fallopian tube. Clearly, the secondary shape must have a larger outer diameter than the inner diameter of the fallopian tube.
  • [0035]
    Conveniently, the present resilient structures are insertable into a catheter, the catheter wall restraining the resilient structure in a straight configuration. As the resilient structure has an outer diameter when in the straight configuration which is less than the inner diameter of the fallopian tube, the catheter containing the present intrafallopian device is easily transcervically introduced. Moreover, the device is readily removed by snaring the resilient structure near the proximal end and pulling proximally on the resilient structure, thereby straightening the resilient structure and allowing it to be withdrawn without injuring the fallopian tube. Alternatively, an electrical current is applied to the device after it is at least partially releasing the fallopian tube, providing permanent sterilization.
  • [0036]
    Referring now to FIG. 1, a first embodiment of the present contraceptive intrafallopian device 10 is formed from a resilient primary coil 12. Primary coil 12 is most easily originally formed as a straight cylindrical coil or spring, preferably having an outer diameter in the range from 0.2 mm to 5 mm, and having a length in the range from 20 mm to 150 mm. Ideally, primary coil 12 has an outer diameter in the range from 0.4 mm to 2 mm and a length in the range from 30 mm to 70 mm. The straight primary coil may then be bent into a variety of secondary shapes.
  • [0037]
    The primary coil 12 of intrafallopian device 10 includes a proximal end 14 and a distal end 16. Between these ends, three loops 20 are formed, each having an inner diameter 22. Located between loops 20 are straight sections 24, which increase the overall cross-section of the intrafallopian device to an overall width 26. Preferably, inner diameter 22 is in the range from 2 mm to 10 mm, while overall width 26 is at least 6 mm, ideally being in the range from 8 mm to 40 mm. Distal and proximal ends 14, 16 each include an atraumatic endcap 18 to prevent injury to the fallopian tube.
  • [0038]
    Preferably, primary coil 12 is formed from a beryllium copper alloy wire. Beryllium copper provides the resilience necessary to avoid expulsion of the device, and also provides the increased effectiveness of a copper contraceptive intrafallopian device. Alternatively, primary coil 12 is formed from a resilient metal, such as stainless steel, platinum, a shape memory alloy, or the like. If such materials are used, primary coil 12 is preferably plated with copper or a copper alloy or otherwise has copper attached.
  • [0039]
    To further reduce the possibility of expulsion of intrafallopian device 10, fibers are optionally carried on primary coil 12. The fibers may be short individual fibers, or may alternatively be wound into primary coil 12. Preferably, the fibers comprise copper, thereby increasing the total copper surface area. Such copper fibers are preferably bonded to primary coil 12 with solder, brazing, a polymeric adhesive, or the like. Alternatively, polyester fibers such as Dacron™, Rayon™, or the like, are bonded to the surface of primary coil 12 using a polymeric adhesive. The polyester fibers promote increased tissue growth around the coil, thus further reducing the possibility of expulsion of the device from the fallopian tube.
  • [0040]
    A secondary shape has been superimposed on the primary coil to form intrafallopian device 10, the secondary shape comprising loops 20 separated by straight sections 24. This secondary shape is herein referred to as a “flower coil.” The flower coil shape is particularly advantageous in that outer diameter 26 is substantially larger than the primary coil diameter, while the individual loops 20 have relatively small inner diameters 22 which will maintain the largest possible anchoring force against the fallopian tube. Minimizing inner diameter 22 also ensures that anchoring force is applied within the fallopian tube, despite the curvature of the fallopian tube.
  • [0041]
    Referring now to FIG. 2, an alternative embodiment of the present contraceptive intrafallopian device 30 includes additional loops to ensure anchoring of the device within the fallopian tube. Alternative embodiment 30 is formed from an elongate primary coil 32 having a proximal end 34 and a distal end (not shown). Elongate primary coil 32 has an outer diameter 36 which is smaller than the isthmus of the fallopian tube, allowing the straightened intrafallopian device to be inserted easily. Elongate primary coil 32 has been bent to form a secondary shape including a larger number of loops 38 than the embodiment of FIG. 1. Loops 38 have an outer diameter 40 which is larger than the inner diameter of the fallopian tube, preventing loops 38 from assuming their relaxed shape. Loops 38 are again separated by straight sections 42 of elongate primary coil 32, increasing the overall intrafallopian device diameter 44.
  • [0042]
    In both embodiments of the present intrafallopian device 10, 30, at least one loop adjacent to the proximal end is disposed proximally of the narrowest portion of the fallopian tube, referred to as the isthmus. Similarly, at least one loop of the intrafallopian device is disposed distally of the isthmus. These proximal and distal loops act as anchors, helping to prevent proximal or distal movement of the intrafallopian device. In the embodiment of FIG. 2, at least one loop is also disposed adjacent to the isthmus of the fallopian tube, further helping to prevent unintentional expulsion.
  • [0043]
    Alternative intrafallopian device 30 may be positioned with multiple loops acting as proximal or distal anchors, or may alternatively have all but the proximal and distal anchor loops disposed along the fallopian tube to act as anchors within the lumen of that body. Advantageously, the embodiment of FIG. 2 is therefore less sensitive to variations in total fallopian tube length.
  • [0044]
    Referring now to FIG. 3, a delivery catheter for the present intrafallopian device comprises an elongate body 52 and a shaft 54. Elongate body 52 includes a lumen 56 in which shaft 54 is disposed, shaft 54 being slidable in the axial direction. Shaft 54 includes a core 58 having a tapered distal end 60, allowing the device to navigate through tortuous bends while retaining the column strength required to advance the device. Core 58 extends proximally through elongate body 52, and is capable of transferring compressive forces through the elongate body. Core 58 is typically formed from stainless steel, a stainless alloy, or the like. Disposed over distal end 60 of core 58 is pusher cap 62. Pusher cap 62 provides a low friction, deformable end piece having a distal coil interface surface 64. Pusher cap 62 is preferably formed of a low friction polymer such as PTFE, or the like.
  • [0045]
    Intrafallopian delivery catheter 50 receives the present intrafallopian device within the distal end of lumen 56 of elongate body 52. Lumen 56 has an inner diameter which is slightly larger than outer diameter 36 of the primary coil. The present intrafallopian device is therefore straightened to a straight configuration as it is loaded proximally into the distal end of lumen 56. Elongate body 52 is sufficiently strong to restrain the primary coil in the straight configuration, but must remain sufficiently flexible to allow maneuvering within the body lumen. Elongate body 52 is preferably formed from an inelastic, flexible material such as polyurethane, PET, or the like.
  • [0046]
    Referring now to FIG. 4, intrafallopian device 10 is released from delivery catheter 50 within the fallopian tube by holding shaft 54 while proximally withdrawing elongate body 52. Distal coil interface surface 64 engages the proximal end 14 of primary coil 12. Initially, primary coil 12 is restrained in a straight configuration by elongate body 52. As elongate body 52 is withdrawn, primary coil 12 is released. When primary coil 12 is unrestrained it forms loop 20; when released within the fallopian tube it will generally be restrained by the tubal wall in a configuration between straight and the relaxed secondary shape. Preferably, the first loop released will form a distal anchor bend 66. Subsequent loops will bias primary coil 12 against the fallopian tube, and form a proximal anchor bend, in that order.
  • [0047]
    Use of the present contraceptive intrafallopian device will be described with reference to FIGS. 5 and 6. A uterine introducer canula 70 is inserted transcervically through a uterus 72 to the region of an ostium 74. Elongate body 52 is then extended distally from canula 70 into a fallopian tube 77, preferably guided under fluoroscopy. Alternatively, a hysteroscope may be used in place of canula 70. Elongate body 52 is maneuvered using a guide wire 78 past an isthmus 80.
  • [0048]
    After elongate body 52 extends past isthmus 80, guide wire 78 is removed. An intrafallopian device according to the present invention is inserted in the proximal end of elongate body 52, the intrafallopian device being restrained in a straight configuration by the elongate body. The device is advanced distally using shaft 54, the shaft and elongate body forming delivery catheter 50 (FIG. 3). Delivery catheter 50 is axially positioned so that at least one loop of the intrafallopian device is within a target region 84 adjacent to isthmus 80. Preferably, at least one loop is distal of target region 84, and at least one loop is proximal of target region 84 to form the distal and proximal anchor bends of the implanted intrafallopian device.
  • [0049]
    Once delivery catheter 50 is properly positioned, elongate body 52 may be axially withdrawn. Shaft 54 axially restrains the intrafallopian device at the target location during withdrawal of elongate body 52, as described regarding FIG. 4. As the distal end of the primary coil is released, the distal loop forms a distal anchor bend 90. Similarly, the proximal loop forms a proximal anchor bend 92. Intermediate loops are restrained within the narrow target region 84, exerting substantial anchoring forces against the walls of the fallopian tube. As seen in FIG. 6, the loops need not assume their relaxed form to provide effective distal or proximal anchors.
  • [0050]
    The present invention further encompasses permanent sterilization by passing a current through the shaft to the intrafallopian device after elongate body 52 has been partially withdrawn, but before the intrafallopian device is fully released. Fallopian tube tissue in contact with the intrafallopian device is dessechated, and thus attached to the present intrafallopian device. This action also causes permanent tubal damage, leading to the formation of scar tissue which encapsulates the intrafallopian device and causes permanent occlusion of the tubal lumen. Clearly, the resilient member/shaft interface must be conductive to allow the present non-surgical method of permanent sterilization.
  • [0051]
    In conclusion, the present invention provides a contraceptive intrafallopian device which may be positioned without surgery. While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. For example, a wide variety of secondary shapes, including open loops, continuous bends, sinusoidal curves, or the like, may be imposed on the primary coil. Therefore, the above description should not be taken as limiting the scope of the invention, which is defined instead solely by the appended claims.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3422813 *21 Jun 196521 Jan 1969Dow CorningMethod for sterilization of males
US3561438 *11 Jul 19689 Feb 1971Canel RobertGynaecological device
US3563235 *18 Sep 196816 Feb 1971Searle & CoIntrauterine contraceptive method
US3722500 *29 Dec 197027 Mar 1973Robinson RAbortive device and method
US3803308 *1 Dec 19709 Apr 1974Searle & CoMethod of contraception with a soluble non-toxic copper or zinc compound
US3805767 *26 Feb 197323 Apr 1974Erb ReneMethod and apparatus for non-surgical, reversible sterilization of females
US3858571 *2 Jul 19737 Jan 1975Arthur I RudolphCornual plug
US3858586 *1 Jun 19737 Jan 1975Martin LessenSurgical method and electrode therefor
US3868956 *5 Jun 19724 Mar 1975Ralph J AlfidiVessel implantable appliance and method of implanting it
US3938527 *13 Jul 197317 Feb 1976Centre De Recherche Industrielle De QuebecInstrument for laparoscopic tubal cauterization
US4003380 *29 Aug 197518 Jan 1977F.L. FisherBipolar coagulation instrument
US4085743 *2 Mar 197625 Apr 1978In Bae YoonMultiple occlusion ring applicator and method
US4135495 *21 May 197523 Jan 1979Borgen Jennings OMethod and means for reversible sterilization
US4136695 *9 Jul 197530 Jan 1979Gynetech-Denver, Inc.Transvaginal sterilization instrument
US4140126 *18 Feb 197720 Feb 1979Choudhury M HasanMethod for performing aneurysm repair
US4143656 *7 Apr 197813 Mar 1979Ortho Pharmaceutical CorporationInstrument and method for inserting an intrauterine contraceptive device
US4158050 *15 Jun 197812 Jun 1979International Fertility Research ProgrammeMethod for effecting female sterilization without surgery
US4181725 *2 May 19771 Jan 1980The Regents Of The University Of MichiganMethod for alleviating psoriasis
US4185618 *26 Jun 197829 Jan 1980Population Research, Inc.Promotion of fibrous tissue growth in fallopian tubes for female sterilization
US4207891 *10 Oct 197817 Jun 1980Population Research IncorporatedDispensing instrument with supported balloon
US4245623 *6 Jun 197820 Jan 1981Erb Robert AMethod and apparatus for the hysteroscopic non-surgical sterilization of females
US4246896 *30 Oct 197827 Jan 1981Dynatech Corp.Intracervical cuff (ICC) for contraception and prevention of venereal disease and applicator therefor
US4326511 *5 Oct 197927 Apr 1982Zimerman Clota EIntrauterine contraceptive device
US4374523 *15 Aug 197522 Feb 1983Yoon In BOcclusion ring applicator
US4503569 *3 Mar 198312 Mar 1985Dotter Charles TTransluminally placed expandable graft prosthesis
US4509504 *28 Sep 19799 Apr 1985Medline AbOcclusion of body channels
US4523590 *25 Oct 198218 Jun 1985Wilfred RothMethod and device for reversible sterilization in mammals
US4572162 *23 Jan 198425 Feb 1986Ortho Pharmaceutical (Canada) Ltd.Method for the detection, location and extraction of an intrauterine device
US4574806 *1 Oct 198411 Mar 1986Cordis CorporationTunnelling device for peripheral vascular reconstruction
US4579110 *18 Nov 19831 Apr 1986Jacques HamouTubular pessary as a contraceptive means
US4595000 *21 May 198417 Jun 1986Jacques HamouTubular pessary as a contraceptive means
US4638803 *30 Nov 198427 Jan 1987Rand Robert WMedical apparatus for inducing scar tissue formation in a body
US4655771 *11 Apr 19837 Apr 1987Shepherd Patents S.A.Prosthesis comprising an expansible or contractile tubular body
US4717387 *25 Jun 19865 Jan 1988Sumitomo Electric Industries Ltd.Catheter
US4724832 *18 Sep 198516 Feb 1988Strubel Bernd JochenSize-variable intrauterine pressay and contraceptive device
US4727866 *3 Sep 19851 Mar 1988Ortho Pharmaceutical (Canada) Ltd.Intrauterine device detection and removal system
US4731052 *14 Jan 198715 Mar 1988Seitz Jr H MichaelMethod for removing tissue and living organisms
US4733665 *7 Nov 198529 Mar 1988Expandable Grafts PartnershipExpandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4805618 *11 Apr 198821 Feb 1989Olympus Optical Co., Ltd.Oviduct closing apparatus
US4808399 *11 Dec 198628 Feb 1989Ceskoslovenska Akademie VedComposition for diagnosing the transport function of the fallopian tube and a method for preparing said composition
US4821741 *5 Oct 198718 Apr 1989Mohajer Reza SBarrier contraceptive
US4824434 *21 Dec 198725 Apr 1989Seitz Jr H MichaelApparatus used in a method for removing tissue and living organisms from human body cavities
US4932421 *23 Jan 198912 Jun 1990Steven KaaliElectrified intrauterine device
US4932422 *12 Jun 198912 Jun 1990Ragheb Gamal AContraceptive device
US4983177 *3 Jan 19908 Jan 1991Wolf Gerald LMethod and apparatus for reversibly occluding a biological tube
US4994069 *2 Nov 198819 Feb 1991Target TherapeuticsVaso-occlusion coil and method
US5002552 *7 Nov 198826 Mar 1991Donn CaseySurgical clip
US5095917 *19 Jan 199017 Mar 1992Vancaillie Thierry GTransuterine sterilization apparatus and method
US5108420 *1 Feb 199128 Apr 1992Temple UniversityAperture occlusion device
US5176692 *9 Dec 19915 Jan 1993Wilk Peter JMethod and surgical instrument for repairing hernia
US5192301 *3 Sep 19919 Mar 1993Nippon Zeon Co., Ltd.Closing plug of a defect for medical use and a closing plug device utilizing it
US5195964 *5 Dec 199123 Mar 1993Research And Education Institute, Inc.Transcervical catheterization cannula
US5197978 *26 Apr 199130 Mar 1993Advanced Coronary Technology, Inc.Removable heat-recoverable tissue supporting device
US5207684 *13 Apr 19924 May 1993Neuro Navigational CorporationSheath for shunt placement for hydrocephalus
US5303719 *25 Jun 199319 Apr 1994Wilk Peter JSurgical method and associated instrument assembly
US5304194 *2 Oct 199219 Apr 1994Target TherapeuticsVasoocclusion coil with attached fibrous element(s)
US5304195 *21 Jan 199319 Apr 1994Target Therapeutics, Inc.Detachable pusher-vasoocclusive coil assembly with interlocking coupling
US5304228 *23 Jul 199219 Apr 1994Prince Martin RMethod for making optical fiber with atraumatic rounded end for use in laser angioplasty
US5312415 *22 Sep 199217 May 1994Target Therapeutics, Inc.Assembly for placement of embolic coils using frictional placement
US5377668 *12 Apr 19933 Jan 1995Optimed Technologies, Inc.Apparatus and method for endoscopic diagnostics and therapy
US5382259 *26 Oct 199217 Jan 1995Target Therapeutics, Inc.Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5382260 *30 Oct 199217 Jan 1995Interventional Therapeutics Corp.Embolization device and apparatus including an introducer cartridge and method for delivering the same
US5382261 *1 Sep 199217 Jan 1995Expandable Grafts PartnershipMethod and apparatus for occluding vessels
US5389089 *13 Oct 199214 Feb 1995Imagyn Medical, Inc.Catheter with angled ball tip for fallopian tube access and method
US5389100 *6 Nov 199114 Feb 1995Imagyn Medical, Inc.Controller for manipulation of instruments within a catheter
US5411549 *13 Jul 19932 May 1995Scimed Life Systems, Inc.Selectively expandable, retractable and removable stent
US5499995 *25 May 199419 Mar 1996Teirstein; Paul S.Body passageway closure apparatus and method of use
US5507768 *6 Jul 199316 Apr 1996Advanced Cardiovascular Systems, Inc.Stent delivery system
US5514176 *20 Jan 19957 May 1996Vance Products Inc.Pull apart coil stent
US5601593 *18 Aug 199511 Feb 1997Willy Rusch AgStent for placement in a body tube
US5601600 *8 Sep 199511 Feb 1997Conceptus, Inc.Endoluminal coil delivery system having a mechanical release mechanism
US5624449 *28 Apr 199529 Apr 1997Target TherapeuticsElectrolytically severable joint for endovascular embolic devices
US5624461 *6 Jun 199529 Apr 1997Target Therapeutics, Inc.Three dimensional in-filling vaso-occlusive coils
US5718711 *15 Oct 199317 Feb 1998Target Therapeutics, Inc.Ultrasoft embolism devices and process for using them
US5725777 *9 Nov 199310 Mar 1998Prismedical CorporationReagent/drug cartridge
US5746692 *8 Apr 19965 May 1998Imagen Medical, Inc.Catheter and endoscope system with distal protruding ball tip and method
US5746769 *22 Oct 19965 May 1998Conceptus, Inc.Endoluminal coil delivery system having a mechanical release mechanism
US5749915 *7 Jun 199512 May 1998Focal, Inc.Polymeric endoluminal paving process
US5755773 *4 Jun 199626 May 1998Medtronic, Inc.Endoluminal prosthetic bifurcation shunt
US5858571 *29 Aug 199712 Jan 1999Shin-Etsu Chemical Co., Ltd.Method of producing hydrogen absorbing alloy powder, and electrode using hydrogen absorbing alloy powder produced by said method
US5876398 *19 Dec 19952 Mar 1999Medtronic, Inc.Method and apparatus for R-F ablation
US5885601 *4 Apr 199723 Mar 1999Family Health InternationalUse of macrolide antibiotics for nonsurgical female sterilization and endometrial ablation
US5895749 *31 Oct 199420 Apr 1999Beth Israel Deaconess Medical CenterMale fertility and contraception home test kits
US5897551 *21 Nov 199427 Apr 1999Myriadlase, Inc.Medical device for applying high energy light and heat for gynecological sterilization procedures
US6019757 *7 Jul 19951 Feb 2000Target Therapeutics, Inc.Endoluminal electro-occlusion detection apparatus and method
US6042590 *16 Jun 199728 Mar 2000Novomedics, LlcApparatus and methods for fallopian tube occlusion
US6066139 *14 May 199623 May 2000Sherwood Services AgApparatus and method for sterilization and embolization
US6068626 *10 Aug 199930 May 2000Adiana, Inc.Method and apparatus for tubal occlusion
US6176240 *7 Jun 199523 Jan 2001Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6178354 *2 Dec 199823 Jan 2001C. R. Bard, Inc.Internal mechanism for displacing a slidable electrode
US6187027 *13 Jan 200013 Feb 2001Target Therapeutics, Inc.Vaso-occlusive devices with heat secured polymer fiber
US6346102 *26 May 200012 Feb 2002Adiana, Inc.Method and apparatus for tubal occlusion
US6357443 *9 Nov 199919 Mar 2002Synergyn Technologies, Inc.Removable fallopian tube plug and associated methods
US6526979 *12 Jun 20004 Mar 2003Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices and methods
US6679266 *28 Mar 200220 Jan 2004Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6705323 *8 Jun 199816 Mar 2004Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices and methods
US20020013589 *18 Dec 199631 Jan 2002Ovion, Inc.Contraceptive system and method of use
US20030029457 *16 Oct 200213 Feb 2003Callister Jeffrey P.Contraceptive system and method of use
US20050045183 *28 Jun 20043 Mar 2005Ovion, Inc.Methods and devices for occluding body lumens and/or for delivering therapeutic agents
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US739878025 Oct 200415 Jul 2008Ams Research CorporationContraceptive system and method of use
US804808624 Feb 20051 Nov 2011Femasys Inc.Methods and devices for conduit occlusion
US804810129 Sep 20081 Nov 2011Femasys Inc.Methods and devices for conduit occlusion
US805266929 Sep 20088 Nov 2011Femasys Inc.Methods and devices for delivery of compositions to conduits
US811320521 Feb 200814 Feb 2012Conceptus, Inc.Contraceptive system and method of use
US823504730 Mar 20067 Aug 2012Conceptus, Inc.Methods and devices for deployment into a lumen
US831685317 Jul 200927 Nov 2012Femasys Inc.Method and devices for conduit occlusion
US831685431 Oct 201127 Nov 2012Femasys Inc.Methods and devices for conduit occlusion
US832419331 Oct 20114 Dec 2012Femasys Inc.Methods and devices for delivery of compositions to conduits
US833655231 Oct 201125 Dec 2012Femasys Inc.Methods and devices for conduit occlusion
US85626283 Apr 200722 Oct 2013Conceptus, Inc.Linear motion delivery system for female sterilization device
US869560624 Nov 201215 Apr 2014Femasys Inc.Methods and devices for conduit occlusion
US870795714 Jul 200829 Apr 2014Bayer Essure Inc.Contraceptive system and method of use
US87079581 Aug 201229 Apr 2014Bayer Essure Inc.Methods and devices for deployment into a lumen
US872690625 Nov 201220 May 2014Femasys Inc.Methods and devices for conduit occlusion
US903405324 Nov 201219 May 2015Femasys Inc.Methods and devices for conduit occlusion
US922088025 Nov 201229 Dec 2015Femasys Inc.Methods and devices for delivery of compositions to conduits
US923812719 Sep 201319 Jan 2016Femasys Inc.Methods and devices for delivering to conduit
US93080236 May 201512 Apr 2016Femasys Inc.Methods and devices for conduit occlusion
US940276231 Mar 20142 Aug 2016Femasys Inc.Methods and devices for conduit occlusion
US955482627 Aug 201131 Jan 2017Femasys, Inc.Contrast agent injection system for sonographic imaging
US9622751 *6 Aug 200918 Apr 2017Boston Scientific Scimed, Inc.Vaso-occlusive devices with textured surfaces
US971354931 Jan 200525 Jul 2017Bayer Healthcare LlcContraceptive with permeable and impermeable components
US20010041900 *23 Jul 200115 Nov 2001Ovion, Inc.Occluding device and method of use
US20030029457 *16 Oct 200213 Feb 2003Callister Jeffrey P.Contraceptive system and method of use
US20050288551 *27 Apr 200529 Dec 2005Ams Research CorporationEndoscopic delivery of medical devices
US20060009798 *31 Jan 200512 Jan 2006Ams Research CorporationMethods and devices for occluding body lumens and/or enhancing tissue ingrowth
US20070244439 *3 Apr 200718 Oct 2007Ams Research CorporationLinear Motion Delivery System for Female Sterilization Device
US20080135054 *21 Feb 200812 Jun 2008Jeffrey P. CallisterContraceptive system and method of use
US20100036412 *6 Aug 200911 Feb 2010Boston Scientific Scimed,Inc.Vaso-occlusive devices with textured surfaces
US20100168514 *4 Jan 20101 Jul 2010Callister Jeffrey PEndoscopic delivery of medical devices
Classifications
U.S. Classification128/831, 128/830
International ClassificationA61F6/06, A61B17/12, A61F6/22, A61F6/18
Cooperative ClassificationA61B17/1215, A61F6/18, A61B17/12022, A61F6/22, A61F6/225, A61B17/12145, A61B2017/1205, A61B17/12099
European ClassificationA61F6/22B, A61B17/12P7C1, A61B17/12P7C3, A61B17/12P5, A61F6/18, A61F6/22
Legal Events
DateCodeEventDescription
16 Jan 2014ASAssignment
Owner name: BAYER ESSURE INC., CALIFORNIA
Free format text: CHANGE OF NAME;ASSIGNOR:CONCEPTUS, INC.;REEL/FRAME:032075/0466
Effective date: 20131025